Skip to main content
Clinical Trials/NCT00822224
NCT00822224CompletedNot Applicable

Use of MEOPA for Elderly With Dementia.

Centre Hospitalier Universitaire de Nice1 site in 1 country50 target enrollmentStarted: January 2009Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50
Locations
1
Primary Endpoint
feasibility of use of MEOPA as tolerance to mask, MEOPA inhalation

Study Overview

Brief Summary

Acute pain is frequent in elderly especially in geriatrics acute care units where painful procedures are often occurring.

MEOPA represents an alternative to opioïd therapy to prevent procedural pain during the treatment of pressure ulcers.

In this study, cognitive impairment and dementia do not limit the use of MEOPA. The new approach in the management of acute procedural pain provides effective and safe analgesia in frail old patients.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
75 Years to — (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • dementia (Folstein scoring between 0 and 25)
  • older than 75
  • health necessitating of painful care for example eschar care

Exclusion Criteria

  • bullous emphysema
  • pneumothorax

Arms & Interventions

1

Experimental

Use of MEOPA during the painful care

Intervention: MEOPA (Drug)

Outcomes

Primary Outcomes

feasibility of use of MEOPA as tolerance to mask, MEOPA inhalation

Time Frame: one time, at the first care with MEOPA

Secondary Outcomes

  • satisfaction rate of patient(one time, at the first care with MEOPA)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials